Meta-analysis of association between genetic variants in COMT and schizophrenia: An update

Schizophrenia Research

Volumn 110, Issue 1-3, 2009, Pages 140-148

  Okochi, Tomo ^a,b   Ikeda, Masashi ^a,c   Kishi, Taro ^a,b   Kawashima, Kunihiro ^a,b   Kinoshita, Yoko ^a,b   Kitajima, Tsuyoshi ^a,b   Yamanouchi, Yoshio ^a,b   Tomita, Makoto ^d   Inada, Toshiya ^e   Ozaki, Norio ^b,f   Iwata, Nakao ^a,b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d INSTITUTE OF STATISTICAL MATHEMATICS   (Japan)

^e SEIWA HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

COMT; Linkage disequilibrium; Meta analysis; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; METHIONINE; VALINE;

ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROL GROUP; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DNA FLANKING REGION; EXON; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; JAPANESE; META ANALYSIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ADULT; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CONFIDENCE INTERVALS; DATABASES, BIBLIOGRAPHIC; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; JAPAN; MALE; METHIONINE; MIDDLE AGED; ODDS RATIO; SCHIZOPHRENIA; VALINE;

EID: 64749090565     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.02.019     Document Type: Article

References (68)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., and Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 40 7 (2008) 827-834
2. Arinami T., Ohtsuki T., Takase K., Shimizu H., Yoshikawa T., Horigome H., Nakayama J., and Toru M. Screening for 22q11 deletions in a schizophrenia population. Schizophr. Res. 52 3 (2001) 167-170
3. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
4. Barnett J.H., Jones P.B., Robbins T.W., and Muller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol. Psychiatry 12 5 (2007) 502-509
5. Benjamini Y., and Hochberg Y. On the adaptive control of the False Discovery Rate in multiple testing with independent statistics. J. Educ. Behav. Statist. 25 1 (2000) 60-83
6. Chen C.H., Lee Y.R., Chung M.Y., Wei F.C., Koong F.J., Shaw C.K., Yeh J.I., and Hsiao K.J. Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. Am. J. Psychiatry 156 8 (1999) 1273-1275
7. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., Kolachana B.S., Hyde T.M., Herman M.M., Apud J., Egan M.F., Kleinman J.E., and Weinberger D.R. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75 5 (2004) 807-821
8. Daniels J.K., Williams N.M., Williams J., Jones L.A., Cardno A.G., Murphy K.C., Spurlock G., Riley B., Scambler P., Asherson P., McGuffin P., and Owen M.J. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am. J. Psychiatry 153 2 (1996) 268-270
9. de Chaldee M., Laurent C., Thibaut F., Martinez M., Samolyk D., Petit M., Campion D., and Mallet J. Linkage disequilibrium on the COMT gene in French schizophrenics and controls. Am. J. Med. Genet. 88 5 (1999) 452-457
10. Diez-Martin J., Hoenicka J., Martinez I., Aragues M., Rodriguez-Jimenez R., Jimenez-Arriero M.A., Ponce G., Rubio G., and Palomo T. COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients. Med. Clin. (Barc) 128 2 (2007) 41-44
11. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25 2 (2003) 115-121
12. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., and Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 12 (2001) 6917-6922
13. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., Feng G.Y., St Clair D., and He L. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry 57 2 (2005) 139-144
14. Funke B., Malhotra A.K., Finn C.T., Plocik A.M., Lake S.L., Lencz T., DeRosse P., Kane J.M., and Kucherlapati R. COMT genetic variation confers risk for psychotic and affective disorders: a case control study. Behav. Brain Funct. 1 (2005) 19
15. Galderisi S., Maj M., Kirkpatrick B., Piccardi P., Mucci A., Invernizzi G., Rossi A., Pini S., Vita A., Cassano P., Stratta P., Severino G., and Del Zompo M. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Neuropsychobiology 52 2 (2005) 83-89
16. Gallinat J., Bajbouj M., Sander T., Schlattmann P., Xu K., Ferro E.F., Goldman D., and Winterer G. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol. Psychiatry 54 1 (2003) 40-48
17. Glatt S.J., Faraone S.V., and Tsuang M.T. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 160 3 (2003) 469-476
18. Goghari V.M., and Sponheim S.R. Divergent backward masking performance in schizophrenia and bipolar disorder: association with COMT. Am. J. Med. Genet., B Neuropsychiatr. Genet. 147B 2 (2008) 223-227
19. Golimbet V., Gritsenko I., Alfimova M., Lebedeva I., Lezheiko T., Abramova L., Kaleda V., and Ebstein R. Association study of COMT gene Val158Met polymorphism with auditory P300 and performance on neurocognitive tests in patients with schizophrenia and their relatives. World J. Biol. Psychiatry 7 4 (2006) 238-245
20. Han D.H., Park D.B., Na C., Kee B.S., and Lee Y.S. Association of aggressive behavior in Korean male schizophrenic patients with polymorphisms in the serotonin transporter promoter and catecholamine-O-methyltransferase genes. Psychiatry Res. 129 1 (2004) 29-37
21. Han D.H., Kee B.S., Min K.J., Lee Y.S., Na C., Park D.B., and Lyoo I.K. Effects of catechol-O-methyltransferase Val158Met polymorphism on the cognitive stability and aggression in the first-onset schizophrenic patients. Neuroreport 17 1 (2006) 95-99
22. Handoko H.Y., Nyholt D.R., Hayward N.K., Nertney D.A., Hannah D.E., Windus L.C., McCormack C.M., Smith H.J., Filippich C., James M.R., and Mowry B.J. Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia. Mol. Psychiatry 10 6 (2005) 589-597
23. Herken H., Erdal M.E., Boke O., and Savas H.A. Tardive dyskinesia is not associated with the polymorphisms of 5-HT2A receptor gene, serotonin transporter gene and catechol-O-methyltransferase gene. Eur. Psychiatry 18 2 (2003) 77-81
24. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., Inada T., Ujike H., and Ozaki N. Association analysis of chromosome 5 GABAA receptor cluster in Japanese schizophrenia patients. Biol. Psychiatry 58 6 (2005) 440-445
25. Ikeda M., Takahashi N., Saito S., Aleksic B., Watanabe Y., Nunokawa A., Yamanouchi Y., Kitajima T., Kinoshita Y., Kishi T., Kawashima K., Hashimoto R., Ujike H., Inada T., Someya T., Takeda M., Ozaki N., and Iwata N. Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. Schizophr. Res. 101 1-3 (2008) 1-8
26. Illi A., Mattila K.M., Kampman O., Anttila S., Roivas M., Lehtimaki T., and Leinonen E. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia. J. Clin. Psychopharmacol. 23 5 (2003) 429-434
27. Inada T., Nakamura A., and Iijima Y. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am. J. Med. Genet., B Neuropsychiatr. Genet. 120 1 (2003) 35-39
28. Iwata Y., Matsumoto H., Minabe Y., Osada N., Nakamura K., Sekizawa T., Suzuki K., Sekine Y., Takei N., and Mori N. Early-onset schizophrenia and dopamine-related gene polymorphism. Am. J. Med. Genet., B Neuropsychiatr. Genet. 116 1 (2003) 23-26
29. Joo E.J., Jeong S.H., Ahn Y.M., Lee K.Y., Chang Yoon S., Kim E.J., Kim S.U., Cho S.C., and Sik Kim Y. No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies. Psychiatry Res. 136 2-3 (2005) 83-91
30. Joober R., Gauthier J., Lal S., Bloom D., Lalonde P., Rouleau G., Benkelfat C., and Labelle A. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch. Gen. Psychiatry 59 7 (2002) 662-663
31. Karayiorgou M., Gogos J.A., Galke B.L., Wolyniec P.S., Nestadt G., Antonarakis S.E., Kazazian H.H., Housman D.E., and Pulver A.E. Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biol. Psychiatry 43 6 (1998) 425-431
32. Kotler M., Barak P., Cohen H., Averbuch I.E., Grinshpoon A., Gritsenko I., Nemanov L., and Ebstein R.P. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am. J. Med. Genet. 88 6 (1999) 628-633
33. Krabbendam L., Isusi P., Galdos P., Echevarria E., Bilbao J.R., Martin-Pagola A., Papiol S., Castano L., and Van Os J. Associations between COMTVal158Met polymorphism and cognition: direct or indirect effects?. Eur. Psychiatry 21 5 (2006) 338-342
34. Kremer I., Pinto M., Murad I., Muhaheed M., Bannoura I., Muller D.J., Schulze T.G., Reshef A., Blanaru M., Gathas S., Goichman R., Rietschel M., Dobrusin M., Bachner-Melman R., Nemanov L., Belmaker R.H., Maier W., and Ebstein R.P. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am. J. Med. Genet., B Neuropsychiatr. Genet. 119 1 (2003) 35-39
35. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., and Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6 3 (1996) 243-250
36. Lee S.G., Joo Y., Kim B., Chung S., Kim H.L., Lee I., Choi B., Kim C., and Song K. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum. Genet. 116 4 (2005) 319-328
37. Li T., Ball D., Zhao J., Murray R.M., Liu X., Sham P.C., and Collier D.A. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol. Psychiatry 5 1 (2000) 77-84
38. Liou Y.J., Tsai S.J., Hong C.J., Wang Y.C., and Lai I.C. Association analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology 43 1 (2001) 11-14
39. Martorell L., Costas J., Valero J., Gutierrez-Zotes A., Phillips C., Torres M., Brunet A., Garrido G., Carracedo A., Guillamat R., Valles V., Guitart M., Labad A., and Vilella E. Analyses of variants located in estrogen metabolism genes (ESR1, ESR2, COMT and APOE) and schizophrenia. Schizophr. Res. 100 1-3 (2008) 308-315
40. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Owen M.J., and O'Donovan M.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 14 3 (2009) 252-260
41. Mukherjee N., Kidd K.K., Pakstis A.J., Speed W.C., Li H., Tarnok Z., Barta C., Kajuna S.L., and Kidd J.R. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol. Psychiatry (2008), advance online publication 24 June 2008
42. Munafo M.R., Bowes L., Clark T.G., and Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol. Psychiatry 10 8 (2005) 765-770
43. Muntjewerff J.W., Gellekink H., den Heijer M., Hoogendoorn M.L., Kahn R.S., Sinke R.J., and Blom H.J. Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia. Eur. Neuropsychopharmacol. 18 2 (2008) 99-106
44. Murphy K.C., Jones L.A., and Owen M.J. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch. Gen. Psychiatry 56 10 (1999) 940-945
45. Neale B.M., and Sham P.C. The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet. 75 3 (2004) 353-362
46. Nicodemus K.K., Kolachana B.S., Vakkalanka R., Straub R.E., Giegling I., Egan M.F., Rujescu D., and Weinberger D.R. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum. Genet. 120 6 (2007) 889-906
47. Numata S., Ueno S., Iga J., Yamauchi K., Hongwei S., Ohta K., Kinouchi S., Shibuya-Tayoshi S., Tayoshi S., Aono M., Kameoka N., Sumitani S., Tomotake M., Kaneda Y., Taniguchi T., Ishimoto Y., and Ohmori T. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci. Lett. 401 1-2 (2006) 1-5
48. Nunokawa A., Watanabe Y., Muratake T., Kaneko N., Koizumi M., and Someya T. No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population. Neurosci. Res. 58 3 (2007) 291-296
49. Ohmori O., Shinkai T., Kojima H., Terao T., Suzuki T., Mita T., and Abe K. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci. Lett. 243 1-3 (1998) 109-112
50. Ohnishi T., Hashimoto R., Mori T., Nemoto K., Moriguchi Y., Iida H., Noguchi H., Nakabayashi T., Hori H., Ohmori M., Tsukue R., Anami K., Hirabayashi N., Harada S., Arima K., Saitoh O., and Kunugi H. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129 Pt 2 (2006) 399-410
51. Owen M.J., Craddock N., and O'Donovan M.C. Schizophrenia: genes at last?. Trends Genet. 21 9 (2005) 518-525
52. Park T.W., Yoon K.S., Kim J.H., Park W.Y., Hirvonen A., and Kang D. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. Eur. Neuropsychopharmacol. 12 4 (2002) 299-303
53. Poyurovsky M., Michaelovsky E., Frisch A., Knoll G., Amir I., Finkel B., Buniak F., Hermesh H., and Weizman R. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study. Neurosci. Lett. 389 1 (2005) 21-24
54. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am. J. Hum. Genet. 69 1 (2001) 124-137
55. Rujescu D., Giegling I., Gietl A., Hartmann A.M., and Moller H.J. A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol. Psychiatry 54 1 (2003) 34-39
56. Sanders A.R., Rusu I., Duan J., Vander Molen J.E., Hou C., Schwab S.G., Wildenauer D.B., Martinez M., and Gejman P.V. Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol. Psychiatry 10 4 (2005) 353-365
57. Sanders A.R., Duan J., Levinson D.F., Shi J., He D., Hou C., Burrell G.J., Rice J.P., Nertney D.A., Olincy A., Rozic P., Vinogradov S., Buccola N.G., Mowry B.J., Freedman R., Amin F., Black D.W., Silverman J.M., Byerley W.F., Crowe R.R., Cloninger C.R., Martinez M., and Gejman P.V. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am. J. Psychiatry 165 4 (2008) 497-506
58. Sazci A., Ergul E., Kucukali I., Kilic G., Kaya G., and Kara I. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women. Brain Res. Mol. Brain Res. 132 1 (2004) 51-56
59. Semwal P., Prasad S., Varma P.G., Bhagwat A.M., Deshpande S.N., and Thelma B.K. Candidate gene polymorphisms among North Indians and their association with schizophrenia in a case-control study. J. Genet. 81 2 (2002) 65-71
60. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., and Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 71 6 (2002) 1296-1302
61. Strous R.D., Bark N., Parsia S.S., Volavka J., and Lachman H.M. Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior. Psychiatry Res. 69 2-3 (1997) 71-77
62. Suzuki T., Iwata N., Kitamura Y., Kitajima T., Yamanouchi Y., Ikeda M., Nishiyama T., Kamatani N., and Ozaki N. Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia. Am. J. Med. Genet., B Neuropsychiatr. Genet. 121B 1 (2003) 7-13
63. Szoke A., Schurhoff F., Meary A., Mathieu F., Chevalier F., Trandafir A., Alter C., Roy I., Bellivier F., and Leboyer M. Lack of influence of COMT and NET genes variants on executive functions in schizophrenic and bipolar patients, their first-degree relatives and controls. Am. J. Med. Genet., B Neuropsychiatr. Genet. 141 5 (2006) 504-512
64. Talkowski M.E., Kirov G., Bamne M., Georgieva L., Torres G., Mansour H., Chowdari K.V., Milanova V., Wood J., McClain L., Prasad K., Shirts B., Zhang J., O'Donovan M.C., Owen M.J., Devlin B., and Nimgaonkar V.L. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 17 5 (2008) 747-758
65. Thaker G.K., Wonodi I., Avila M.T., Hong L.E., and Stine O.C. Catechol O-methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report. Am. J. Psychiatry 161 12 (2004) 2320-2322
66. Williams H.J., Glaser B., Williams N.M., Norton N., Zammit S., MacGregor S., Kirov G.K., Owen M.J., and O'Donovan M.C. No association between schizophrenia and polymorphisms in COMT in two large samples. Am. J. Psychiatry 162 9 (2005) 1736-1738
67. Wonodi I., Stine O.C., Mitchell B.D., Buchanan R.W., and Thaker G.K. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am. J. Med. Genet., B Neuropsychiatr. Genet. 120 1 (2003) 47-50
68. Yu R., Zhang X.N., Huang X.X., Ding S.P., and Li J.C. Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study. Am. J. Med. Genet., B Neuropsychiatr. Genet. 144 4 (2007) 570-573